Developed in collaboration with MD Anderson Cancer Center, the RaySearch groundbreaking image-guided ablation confirmation solution, backed by the COVER-ALL randomized phase II trial, offers greater control and confidence when treating challenging tumors, potentially improving outcomes and reducing complications.
Software-based approaches have been shown to improve the precision of ablation margin evaluation when compared to visual assessments, ultimately enhancing clinical outcomes and promoting consistent, accountable practice across institutions.(1)
RaySearch's history of working in close collaboration with leading cancer centers to bring scientific advancements faster to the clinical world helped us bring our image-guided thermal ablation confirmation solution to life.
Our solution enables advanced image-guided ablation by combining deformable registration with Deep Learning Segmentation (DLS) for automatic delineation and precise target conformation. Combining fast algorithms and streamlined workflows brings a powerful, efficient, and intelligent solution that enables state-of-the-art ablation treatments in just minutes.
For over 25 years, RaySearch Laboratories has advanced cancer treatment through software innovation. RaySearch’s software is used and trusted by nearly 1,200 clinics in 54 countries, including some of the world's leading clinics.
Achieving optimal ablation margins is essential to achieve local tumor control when leveraging thermal ablation as a therapeutic approach to cancer care. Our advanced image-guided ablation solution has been highlighted in the COVER-ALL randomized phase II trial.(2) The use of software-based assessment for thermal ablation resulted in demonstrated optimal ablation margins in 84% of cases, which translated into a considerable reduction in local tumor progression when compared to the visual assessment.
RaySearch Laboratories builds software trusted by many of the world's leading cancer centers.
Our solutions can support your practice and shape the future of interventional oncology. Come by our booth and talk to our experts to discover more.
SUNDAY 29 NOVEMBER | 1:00 PM
RaySearch Laboratories' software journey toward comprehensive cancer care
Join our RaySearch Experts as we present how almost three decades of cancer care software development led to a new solution for image-guided ablation, and where that journey goes next.
*RaySearch products and functionalities may be under ongoing development and/or subject to regulatory review and may not be cleared or approved in all jurisdictions. Some products or functionalities described may not be available for clinical use or for sale in the United States or Canada.
Custom scripting is user‑defined and intended to support clinical workflows in RaySearch systems, including RayStation and RayCare. Scripts are developed, validated, and used under the user’s responsibility and are not medical device features or clinical decision‑making functions of RaySearch products.
(1) RaySearch Laboratories AB. (2017, April 20). RayStation dose calculation algorithms [View white paper]
(2) RaySearch Laboratories AB. (n.d.). Future-ready radiotherapy at Iridium Network: Scaling automation with RaySearch [View case study]
